HepBest Tenofovir Alafenamide (TAF) 25mg | Mylan India Generic | GLT

Generic Information: HepBest (India)

HepBest is Mylan's — now Viatris' — tenofovir alafenamide single-agent tablet, each film-coated tablet containing tenofovir alafenamide fumarate equivalent to 25 mg of tenofovir alafenamide. It is not a combination product and does not contain emtricitabine. HepBest is a modern prodrug of tenofovir developed for chronic hepatitis B, designed to deliver more drug into liver cells while keeping less in the bloodstream, which spares the kidneys and bone compared with the older tenofovir disoproxil form.

What Is Tenofovir Alafenamide (HepBest) Used For?

HepBest treats chronic hepatitis B virus infection in adults with compensated liver disease. By suppressing HBV replication over the long term, it lowers the viral load, reduces liver inflammation and slows the progression toward cirrhosis and liver cancer. It is a first-line option in international hepatitis B guidelines because of its potency and its improved kidney and bone safety profile.

How Does HepBest Work?

Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor that targets the HBV polymerase. As a prodrug it is activated preferentially inside hepatocytes, where it is converted to tenofovir diphosphate, which the viral polymerase mistakes for a natural nucleotide and incorporates into growing HBV DNA, terminating the chain and stopping replication. Because most of the drug is activated in the liver, far less circulates in the blood, which is what protects the kidneys and bone.

Indications

HepBest is indicated for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease, including patients with evidence of active viral replication and elevated liver enzymes or histological activity. It is also used in adolescents aged twelve and older who weigh at least 35 kg. It is not a treatment for HIV-1, and in HBV/HIV co-infection it must be used only as part of a full antiretroviral regimen to avoid selecting HIV resistance.

Dosage

The standard dose is one 25 mg tablet taken once daily with food, because food increases its absorption. Treatment is long-term — typically years — and is continued under specialist supervision with regular monitoring of viral load, liver enzymes and kidney function. Patients should not stop on their own, as stopping hepatitis B therapy can trigger a severe flare of the infection.

Side Effects

HepBest is generally well tolerated; the most commonly reported effects include headache, nausea, fatigue, abdominal pain and cough. Compared with tenofovir disoproxil, it causes significantly less kidney toxicity and bone mineral density loss, which is its main clinical advantage. Rare but important considerations include lactic acidosis with liver enlargement, and the risk of hepatitis B flare if treatment is stopped abruptly.

Storage

HepBest tablets are stored at room temperature, below 30°C, in the original container away from moisture and light, with no refrigeration needed. They ship by ambient-condition courier, and GLT dispatches from a Hong Kong-licensed facility with batch documentation and a certificate of analysis.

Why Choose HepBest Through GLT?

HepBest offers tenofovir alafenamide — the newer, kidney- and bone-sparing form of tenofovir — at an Indian generic price point, an attractive combination for long-term hepatitis B treatment. GLT's Hong Kong base provides documented, traceable cross-border access to this Mylan/Viatris product for overseas patients and importing pharmacies.

How to Order

To order HepBest (tenofovir alafenamide) from GLT, contact us on WhatsApp at +86 15234153837 or by email at [email protected]. We confirm stock, pack options and delivery timelines to your country, and dispatch from a Hong Kong-licensed facility.

FAQ

Is HepBest the same as emtricitabine/tenofovir? No — HepBest is tenofovir alafenamide (TAF) 25 mg single agent for hepatitis B, not the emtricitabine/tenofovir combination used for HIV.

What is the advantage of TAF over TDF? Tenofovir alafenamide concentrates in liver cells, so it protects the kidneys and bone better than tenofovir disoproxil at an effective dose.

Is it a cure for hepatitis B? It is a long-term suppressive therapy that controls the virus, not a cure; treatment is typically continued for years under specialist care.